Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer

Sinja Taavitsainen; Alexander W. Wyatt; Matti Annala; Elisa Ledet; Kevin Beja; Patrick J. Miller; Marcus Moses; Matti Nykter; Kim N. Chi; Oliver Sartor

doi:10.1200/PO.19.00014

Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer

Sinja Taavitsainen, Alexander W. Wyatt, Matti Annala, Elisa Ledet, Kevin Beja, Patrick J. Miller, Marcus Moses, Matti Nykter, Kim N. Chi, Oliver Sartor

BioMediTech

Research output: Contribution to journal › Article › Scientific › peer-review

13 Citations (Scopus)

Original language	English
Journal	JCO precision oncology
Volume	3
DOIs	https://doi.org/10.1200/PO.19.00014
Publication status	Published - 2019
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/PO.19.00014

http://urn.fi/URN:NBN:fi:tuni-201909273572

Cite this

@article{812130d34e4b469a8764eca38ecc836a,

title = "Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer",

author = "Sinja Taavitsainen and Wyatt, {Alexander W.} and Matti Annala and Elisa Ledet and Kevin Beja and Miller, {Patrick J.} and Marcus Moses and Matti Nykter and Chi, {Kim N.} and Oliver Sartor",

year = "2019",

doi = "10.1200/PO.19.00014",

language = "English",

volume = "3",

}

TY - JOUR

T1 - Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer

AU - Taavitsainen, Sinja

AU - Wyatt, Alexander W.

AU - Annala, Matti

AU - Ledet, Elisa

AU - Beja, Kevin

AU - Miller, Patrick J.

AU - Moses, Marcus

AU - Nykter, Matti

AU - Chi, Kim N.

AU - Sartor, Oliver

PY - 2019

Y1 - 2019

U2 - 10.1200/PO.19.00014

DO - 10.1200/PO.19.00014

M3 - Article

VL - 3

ER -